Brief: FDA Issues Clearance For Rewalk 7 Exoskeleton
13/03/2025 14:57
March 13 (Reuters) - Lifeward Ltd 2RW.MU: FDA ISSUES CLEARANCE FOR REWALK 7 EXOSKELETON LIFEWARD LTD - TO BEGIN SALES OF REWALK 7 IN U.S. Source text: ID:nGNXbdrmSP Further company coverage: 2RW.MU ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lifeward
See all newsBrief: Lifeward On Oct 4, Rami Aviram Informed Will Not Assume Role Of CFO At Lifeward - SEC Filing
NASDAQ RESUMED AT 09:43 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:38 AM
Brief: Lifeward Appoints Josh Hexter Interim CEO, Rami Aviram CFO
Brief: Nano Dimension Appoints Nadav Kidron To Board Of Directors To Chair Strategy And Capital Allocation Committee